Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).
Giard S, Chauvet MP, Penel N, Mignotte H, Martel P, Tunon de Lara C, Gimbergues P, Dessogne P, Classe JM, Fondrinier E, Marmousez T. Giard S, et al. Among authors: fondrinier e. Ann Oncol. 2010 Aug;21(8):1630-1635. doi: 10.1093/annonc/mdp586. Epub 2010 Jan 20. Ann Oncol. 2010. PMID: 20089557 Free article.
A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
Houvenaeghel G, Nos C, Giard S, Mignotte H, Esterni B, Jacquemier J, Buttarelli M, Classe JM, Cohen M, Rouanet P, Penault Llorca F, Bonnier P, Marchal F, Garbay JR, Fraisse J, Martel P, Fondrinier E, Tunon de Lara C, Rodier JF. Houvenaeghel G, et al. Among authors: fondrinier e. Eur J Surg Oncol. 2009 Jul;35(7):690-5. doi: 10.1016/j.ejso.2008.10.003. Epub 2008 Nov 28. Eur J Surg Oncol. 2009. PMID: 19046847
Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
Rodier JF, Velten M, Wilt M, Martel P, Ferron G, Vaini-Elies V, Mignotte H, Brémond A, Classe JM, Dravet F, Routiot T, de Lara CT, Avril A, Lorimier G, Fondrinier E, Houvenaeghel G, Avigdor S. Rodier JF, et al. Among authors: fondrinier e. J Clin Oncol. 2007 Aug 20;25(24):3664-9. doi: 10.1200/JCO.2006.08.4228. Epub 2007 May 7. J Clin Oncol. 2007. PMID: 17485709 Clinical Trial.
Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.
Tunon-de-Lara C, Lemanski C, Cohen-Solal-Le-Nir C, de Lafontan B, Charra-Brunaud C, Gonzague-Casabianca L, Mignotte H, Fondrinier E, Giard S, Quetin P, Auvray H, Cutuli B. Tunon-de-Lara C, et al. Among authors: fondrinier e. Eur J Surg Oncol. 2010 Dec;36(12):1165-71. doi: 10.1016/j.ejso.2010.09.001. Eur J Surg Oncol. 2010. PMID: 20889280
Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.
Cutuli B, Lemanski C, Fourquet A, de Lafontan B, Giard S, Meunier A, Pioud-Martigny R, Campana F, Marsiglia H, Lancrenon S, Mery E, Penault-Llorca F, Fondrinier E, Tunon de Lara C. Cutuli B, et al. Among authors: fondrinier e. Br J Cancer. 2009 Apr 7;100(7):1048-54. doi: 10.1038/sj.bjc.6604968. Epub 2009 Mar 10. Br J Cancer. 2009. PMID: 19277037 Free PMC article.
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B, Lemanski C, Le Blanc-Onfroy M, de Lafontan B, Cohen-Solal-Le-Nir C, Fondrinier E, Mignotte H, Giard S, Charra-Brunaud C, Auvray H, Gonzague-Casabianca L, Quétin P, Fay R. Cutuli B, et al. Among authors: fondrinier e. Cancer Radiother. 2013 Jun;17(3):196-201. doi: 10.1016/j.canrad.2013.01.011. Epub 2013 Mar 26. Cancer Radiother. 2013. PMID: 23538041
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F. Mignotte H, et al. Among authors: fondrinier e. Int J Cancer. 1998 May 4;76(3):325-30. doi: 10.1002/(sici)1097-0215(19980504)76:3<325::aid-ijc7>3.0.co;2-x. Int J Cancer. 1998. PMID: 9579567
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study.
Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, Seince N, Thomas V, Levêque J, Barranger E, Darai E, Uzan S, Houvenaeghel G, Rouzier R. Coutant C, et al. Among authors: fondrinier e. J Clin Oncol. 2009 Jun 10;27(17):2800-8. doi: 10.1200/JCO.2008.19.7418. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349546
Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes.
Werkoff G, Lambaudie E, Fondrinier E, Levêque J, Marchal F, Uzan M, Barranger E, Guillemin F, Darai E, Uzan S, Houvenaeghel G, Rouzier R, Coutant C. Werkoff G, et al. Among authors: fondrinier e. J Clin Oncol. 2009 Dec 1;27(34):5707-12. doi: 10.1200/JCO.2009.21.9139. Epub 2009 Oct 13. J Clin Oncol. 2009. PMID: 19826125
66 results